Anjie Liu

Anjie Liu is the Co-founder and Chief Executive Officer of Kiwi Biosciences, an emerging biotechnology startup focused on developing advanced gastrointestinal health and wellness solutions. She previously earned a joint concentration degree in physics and comparative literature from Harvard University in 2017 before formally transitioning her professional focus toward the biological sciences. Motivated by her own lifelong struggles with chronic digestive issues, Liu developed a novel enzymatic formulation designed to help individuals process specific dietary trigger foods. This interdisciplinary scientific research directly led to the successful creation and commercialization of FODZYME, a targeted enzyme blend engineered specifically for patients managing complex FODMAP sensitivities. Her current professional work centers on scaling the commercial operations of Kiwi Biosciences and advancing specialized dietary supplements that bridge the gap between rigorous scientific research and everyday human digestive wellness.